v3.25.4

EARNINGS PER SHARE (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Earnings Per Share [Abstract]
(Loss) income from continuing operations	$ (46,609)	$ 7,167
Gain (loss) from discontinued operations	885	0
Net (loss) income	$ (45,724)	$ 7,167
Basic weighted-average common shares (in shares)	12,826,078	6,832,982
Dilutive impact of share-based awards (in shares)	0	50,929
Diluted weighted-average common shares (in shares)	12,826,078	6,883,911
Basic net (loss) income per share:
Basic (loss) income from continuing operations (in USD per shares)	$ (3.63)	$ 1.05
Basic gain (loss) from discontinued operations (in USD per shares)	0.07	0
Basic net (loss) income per share (in USD per shares)	(3.56)	1.05
Diluted net (loss) income per share:
Diluted (loss) income from continuing operations (in USD per shares)	(3.63)	1.04
Diluted gain (loss) from discontinued operations (in USD per shares)	0.07	0
Diluted net (loss) income per share (in USD per shares)	$ (3.56)	$ 1.04
Antidilutive common share equivalents (in shares)		3,348,161

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

PRECISION BIOSCIENCES INC 10-K